Literature DB >> 17159252

Cushing's disease arising from a clinically nonfunctioning pituitary adenoma.

Luiz Roberto Salgado1, Márcio Carlos Machado, Arthur Cukiert, Bernardo Liberman, Cristina Takami Kanamura, Venancio Avancini Ferreira Alves.   

Abstract

A 49-yr-old woman with a large pituitary tumor leading to visual loss and galactorrhea- amenorrhea was submitted to transcranial pituitary surgery, when a clinically nonfunctioning pituitary adenoma was partially removed. Histopathology and immunohistochemistry confirmed the diagnosis of "non-secreting atypical adenoma." At that time, serum and urinary free cortisol were normal, with low T4 levels and hyperprolactinemia. The patient was discharged on thyroxine and bromocriptine and treated with conventional radiotherapy. Two years later, she presented high free urinary cortisol levels and a positive ACTH response to desmopressin testing on dexametasone 2 mg overnight. A pituitary biopsy confirmed aggressive growth as well as positive immunoreactivity for ACTH, p53, Ki-67, and c-erb-B2. The patient was then treated with radiosurgery on ketoconazole therapy. The overall clinical, laboratory, and pathological data suggest a transition from a clinically nonfunctioning to a hypersecreting ACTH-producing tumor. Putative mechanisms of tumor transformation and the possibility of a silent corticotropinoma evolving into clinical Cushing s syndrome are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 17159252     DOI: 10.1385/ep:17:2:191

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  21 in total

1.  p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.

Authors:  K Thapar; B W Scheithauer; K Kovacs; P J Pernicone; E R Laws
Journal:  Neurosurgery       Date:  1996-04       Impact factor: 4.654

2.  The development of Cushing's syndrome from a previously silent pituitary tumour.

Authors:  M E Cooper; R M Murray; R Kalnins; J Woodward; G Jerums
Journal:  Aust N Z J Med       Date:  1987-04

3.  Pituitary Cushing's disease arising from a previously non-functional corticotrophic chromophobe adenoma.

Authors:  N J Vaughan; C M Laroche; I Goodman; M J Davies; J S Jenkins
Journal:  Clin Endocrinol (Oxf)       Date:  1985-02       Impact factor: 3.478

4.  Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission.

Authors:  E L Gogel; P R Salber; J B Tyrrell; M L Rosenblum; J W Findling
Journal:  Arch Intern Med       Date:  1983-05

5.  Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.

Authors:  R G Gheri; W Boddi; F Ammannati; J Olivotto; C Nozzoli; A Franchi; L Bordi; M L Luisi; P Mennonna
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

6.  Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody.

Authors:  K Thapar; K Kovacs; B W Scheithauer; L Stefaneanu; E Horvath; P J Pernicone; D Murray; E R Laws
Journal:  Neurosurgery       Date:  1996-01       Impact factor: 4.654

7.  The c-erbB-2/neu proto-oncogene in human pituitary tumours.

Authors:  S Ezzat; L Zheng; H S Smyth; S L Asa
Journal:  Clin Endocrinol (Oxf)       Date:  1997-05       Impact factor: 3.478

8.  Metamorphosis of a non-functioning pituitary adenoma to Cushing's disease.

Authors:  E U Tan; M S Ho; C R Rajasoorya
Journal:  Pituitary       Date:  2000-10       Impact factor: 4.107

9.  Pituitary Carcinomas.

Authors:  Wolfgang Saeger; Dorothee Lubke
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

10.  Secretion of high-molecular-weight adrenocorticotropic hormone from a pituitary adenoma in a patient without Cushing stigmata. Case report.

Authors:  Akira Matsuno; Ryo Okazaki; Yutaka Oki; Tadashi Nagashima
Journal:  J Neurosurg       Date:  2004-11       Impact factor: 5.115

View more
  9 in total

1.  The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3.

Authors:  Alberto Righi; Marco Faustini-Fustini; Luca Morandi; Valentina Monti; Sofia Asioli; Diego Mazzatenta; Antonella Bacci; Maria Pia Foschini
Journal:  Endocrine       Date:  2016-08-04       Impact factor: 3.633

Review 2.  Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.

Authors:  Fabienne Langlois; Dawn Shao Ting Lim; Chris G Yedinak; Isabelle Cetas; Shirley McCartney; Justin Cetas; Aclan Dogan; Maria Fleseriu
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

3.  Symptomatic cystic degeneration of a clinically silent corticotroph tumor of the pituitary gland.

Authors:  Michael T Walsh; William T Couldwell
Journal:  Skull Base       Date:  2010-09

Review 4.  Silent (clinically nonfunctioning) pituitary adenomas.

Authors:  Sarah E Mayson; Peter J Snyder
Journal:  J Neurooncol       Date:  2014-03-28       Impact factor: 4.130

5.  Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor.

Authors:  Marie S Thearle; Pamela U Freda; Jeffrey N Bruce; Steven R Isaacson; Yoomi Lee; Robert L Fine
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

Review 6.  Modification of hormonal secretion in clinically silent pituitary adenomas.

Authors:  Tania Daems; Johan Verhelst; Alex Michotte; Pascale Abrams; Dirk De Ridder; Roger Abs
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 7.  Clinical and Pathological Aspects of Silent Pituitary Adenomas.

Authors:  Juliana Drummond; Federico Roncaroli; Ashley B Grossman; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

8.  Metachronous Double Pituitary Adenoma with Altered Transcriptional Factor Profile: A Case Report and Literature Review.

Authors:  Akira Taguchi; Yasuyuki Kinoshita; Atsushi Tominaga; Vishwa Jeet Amatya; Yukio Takeshima; Fumiyuki Yamasaki
Journal:  NMC Case Rep J       Date:  2021-10-07

9.  Cushing Disease After Treatment of Nonfunctional Pituitary Adenoma: A Case Report and Literature Review.

Authors:  Hongjuan Fang; Rui Tian; Huanwen Wu; Jian Xu; Hong Fan; Jian Zhou; Liyong Zhong
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.